About Mito Foundation
It’s a wrap for Global Mitochondrial Disease Awareness week 2018, thank you to everyone who participated!
First IVF Baby Turns 40
Happy 40 birthday Louise Brown! Louise’s birth was ground breaking and provided hope to millions of couples.
New research into nucleoside therapy aims to develop a treatment for deadly mitochondrial disease
Read our media release about a pioneering project we are co-funding with The Lily Foundation.
Mito Connect Call
22 November 2018
Hobart Support Group
24 November 2018
29 November – 1 December 2018
EXPERT REACTION: Senate report on allowing ‘three person IVF’ to prevent mitochondrial disease
Read about expert reactions to the Senate Report on mitochondrial donation.
Stealth Raises $100M to Advance Elamipretide as Treatment for Mitochondrial Diseases
Further development of Elamipretide as treatment for Leber’s hereditary optic neuropathy (LHON), mitochondrial myopathy, Barth syndrome, and age-related macular degeneration.
FDA Grants NeuroVive’s KL1333 Orphan Drug Status for Treatment of Mitochondrial Diseases
Orphan Drug Designation of compound KL1333 is a positive step towards bringing such treatment to patients of inherited mitochondrial respiratory chain diseases in the US.